Navigation Links
Leslie Zacks Joins Arbor Pharmaceuticals as General Counsel and Chief Compliance Officer
Date:2/21/2012

ATLANTA, Feb. 21, 2012 /PRNewswire/ -- Arbor Pharmaceuticals, a specialty pharmaceutical company based in Atlanta, GA, announced today that Leslie Zacks has joined the company as General Counsel and Chief Compliance Officer.  Mr. Zacks has a distinguished legal career and most recently held positions of increasing responsibility at Shionogi Pharma, Inc. (previously Sciele Pharma).  While at Shionogi, Leslie built the company's legal department and served on the company's executive leadership team where he was responsible for all legal, IP and compliance functions.

Mr. Zacks has been a practicing attorney in Atlanta, Georgia since 1994.  He was the Executive Vice President, General Counsel and Chief Compliance Officer at Shionogi Pharma, Inc. from 2004-2010.  From 2002 to 2004, Mr. Zacks worked at Hunton & Williams, LLP where he was a partner in the Intellectual Property Litigation department.  Mr. Zacks is a registered patent attorney who has held associate positions at Powell, Goldstein, Frazer & Murphy, LLP (now Bryan Cave, LLP) and at Carlock, Copeland and Stair, LLP.  Mr. Zacks holds a J.D. and a B.A. in English from the University of Florida.

Ed Schutter, President and CEO of Arbor, commented, "We are pleased that Leslie has joined Arbor in this significant role for the company.  Leslie has deep experience in patent law, mergers and acquisitions, compliance, and in many other key areas critical to Arbor as we continue our significant growth."

Mr. Zacks added, "I am pleased to be joining Arbor at this important point in the company's growth.  The company is well positioned to execute on its plan, and I look forward to building on Arbor's success in my new role."

About Arbor Pharmaceuticals, Inc.

Arbor Pharmaceuticals, headquartered in Atlanta, Georgia, is a specialty pharmaceutical company currently focused on the cardiovascular and pediatric markets. The company intends to become a leading specialty pharmaceutical company by actively licensing, developing and commercializing late-stage products for specialty focused conditions. Arbor currently markets multiple NDA and ANDA approved products with several more in development.

For more information regarding Arbor Pharmaceuticals or any of its products, visit www.arborpharma.com or send email inquiries to info@arborpharma.com.  


'/>"/>
SOURCE Arbor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
2. Zacks Rates CardioGenics Outperform With Six-Month Target of $1.22
3. Zacks Investment Research Initiates Coverage on Viral Genetics
4. Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals
5. The Zacks Analyst Blog Highlights: Pfizer, Bristol - Myers Squibb, Eli Lilly, Forest Laboratories and Abbott Laboratories
6. Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo
7. Zacks Releases Four Powerful Buy Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver
8. The Zacks Analyst Blog Highlights: UnitedHealth Group, Aetna, WellPoint, CIGNA and Wright Medical Group
9. Zacks Voice of the People highlights opportunities with Walgreen, Occidental Petroleum and Brown & Brown
10. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
11. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... , May 23, 2017  Leaf Healthcare, ... innovative medical devices for pressure ulcer prevention, will ... American Association of Critical Care Nurses, National Teaching ... 22-25. The Leaf Patient Monitoring System ... for the hospital environment.  The system seamlessly tracks ...
(Date:5/18/2017)... 18, 2017  Two Bayer U.S. Pharmaceutical leaders received ... its recent 28 th Woman of the ... showcases HBA,s longstanding mission of furthering the advancement and ... Cindy Powell-Steffen , senior director of brand ... and Libby Howe , a regional business manager ...
(Date:5/15/2017)... 15, 2017 Enterin Inc., a privately-held CNS pharmaceutical ... novel compounds to treat Parkinson,s disease (PD), has enrolled the ... Phase 1/2a randomized, controlled, multicenter study involving patients with PD ... 50 patients over a 9-to-12-month period. The first stage is ... with PD. Participating sites include Denver , ...
Breaking Medicine Technology:
(Date:5/29/2017)... ... ... The quest to develop a cure for HIV has long been plagued by ... has a knack for lying dormant in immune cells at levels undetectable to all ... Graduate School of Public Health announced today in Nature Medicine that they’ve created a ...
(Date:5/28/2017)... Melbourne, FL (PRWEB) , ... May 28, 2017 ... ... Partners of America (PPOA), is proud to announce that Jorge Fernandez-Silva, M.D., has ... comprehensive interventional pain management, a specialty that concentrates on minimally invasive techniques to ...
(Date:5/27/2017)... ... May 26, 2017 , ... A May 8 article ... for colds or respiratory issues that are not responsive to antibiotics nevertheless obtain prescriptions ... may be largely responsible for the problem both in Canada and the United States. ...
(Date:5/27/2017)... ... May 27, 2017 , ... From May 21-23, hearing healthcare professionals ... event was held at the Marriott Syracuse Downtown Hotel in Syracuse, New York. ... network of independent hearing healthcare providers to help them stay ahead in the industry. ...
(Date:5/26/2017)... ... May 26, 2017 , ... The American Parkinson Disease Association’s ... eighty-nine grant submissions all vying for nearly $1,000,000 in funding that will be ... The American Parkinson Disease Association (APDA) is focused on advancing scientific research that ...
Breaking Medicine News(10 mins):